Live data — every record is aggregated from real public sources. VialGrade never sells; it links out to the vendor.
VialGrade
All compounds
Nootropic peptide
Live data

Cerebrolysin

Cognitive & mood

A brain-derived peptide mixture studied in neuroprotection and recovery research.

FPF-1070

Get told when a price moves or a lab test changes.

Observed median price

$153

Δ —
Every observation
DateObserved
$49.99
$179.00
$70.00
$70.00
$70.00
$70.00
$70.00
$70.00
$70.00
$70.00
$70.00
$70.00
$70.00
$70.00
$70.00

Not enough listings with 30 days of checks to summarise a change — 0 of 5 qualify so far.

5

Active listings

0

Independent lab tests

$50–$560

Observed price range

2

Known aliases

Understand this compound

What is Cerebrolysin?

Widely studieda.k.a. FPF-1070

A mixture of small protein pieces made from purified pig brain, given as an injection in some countries to support recovery after strokes and in dementia. Not approved in the US.

Cognitive & mood
⚠

Good to know: Effect sizes in meta-analyses are modest and inconsistent across trials, and as an animal-tissue-derived biologic it carries a theoretical risk of impurity or immunogenic reaction not present with single, defined peptides.

How does Cerebrolysin work?

The science

A mixture of low-molecular-weight peptide fragments and free amino acids derived from purified pig brain protein, thought to stimulate endogenous neurotrophic factor production and provide direct neurotrophic support.

Mechanism of action from published research — how the molecule behaves, not a claim about any product or any human-use effect.

What is Cerebrolysin researched for?

Studied for stroke recovery, traumatic brain injury, and vascular and Alzheimer's dementia.

  • Cognitive & moodStudied in memory, focus, mood, and neuroprotection research.
How far has the research gone?

Widely studied — evaluated in 50+ randomized controlled trials and approved in 45+ countries (e.g., Russia, Austria, China, South Korea) for stroke, TBI, and dementia; not FDA-approved in the US.

Where the science stands — an approved drug is not the same as the research-grade material a vendor sells, which is unregulated regardless.

What should I check before buying?
  • Independent purity. Look for a third-party COA (Janoshik or MZ) showing a measured purity — not just a number the vendor typed.
  • Batch match. The strongest evidence is a certificate for the exact batch you’ll receive, attributed to this vendor — check the cross-verification on the listing.
  • Vendor reputation. See how the vendor is talked about in the community before trusting a new name.

Research context only — VialGrade never gives dosing, medical, or human-use guidance.

Current market

The Cerebrolysin market

Every Cerebrolysin listing we track — 5 in all. The standout picks first where the evidence supports them, then the full table, ranked by what a milligram really costs wherever the vendor published a strength we can read.

Open full market

Compare by real cost

Every Cerebrolysin listing, cheapest per mg first

Sticker prices hide the size, so listings are ranked by what a milligram actually costs — with independently tested purity where it exists.

#VendorSizePricePer mgTested purityReal $/active mg
1Umbrella LabsUnavailable60mg total$50$0.83/mg——View
2Ascend Bio Labs600mg total60MG / 10 Vials each$560$0.93/mg——View
3Ascend Bio Labs180mg total60MG / 3 Vials each$179$0.99/mg——View
4Ascend Bio Labs120mg total60MG / 2 Vials each$126$1.05/mg——View
5Ascend Bio Labs60mg total$70$1.17/mg——View

Open the full Cerebrolysin market

Real $/active mg divides the price-per-mg by the measured purity — the honest cost of the actual peptide, so a 90%-pure vial isn’t compared as if it were 99%. Too cheap? flags a listing far below the market rate — often underdosing or a fake, not a deal. The crown marks the cheapest non-outlier; best value marks the lowest real cost per active mg. A vendor shown as Unavailable or Low stock is priced here but not currently buyable.

What the research says

Scientific evidence & regulatory status

What the published literature actually shows about Cerebrolysin — separate from any vendor’s marketing. Each finding links to its paper. This is education, not medical or dosing advice.

Regulatory status

No FDA-approved drug

Not FDA-approved and holds no EU-wide marketing authorization from the EMA; a porcine brain-derived peptide preparation authorized nationally in individual countries (Austria has licensed it since 1996) and still trialed there for stroke.

US legal status

Research-use-only — not FDA-approved

Sold “for research use only,” this compound is not FDA-approved for human use and has not been evaluated for safety, purity, or sterility in people. It is generally not a scheduled controlled substance, so buying it as a research chemical is typically not itself a drug crime — but marketing or using it as a drug is not lawful, and it is not a dietary supplement.

Read the full US law →

General information, not legal or medical advice. VialGrade sells nothing and encourages no human use.

Research notes aren’t product proof

Research summaries describe published literature and market data only. They do not establish the identity, quality, safety, or legal status of any listed physical product.